Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales. - Wikidata - awgldk - TriplyDB

Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales.

Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales.

http://www.wikidata.org/entity/Q38133728

about

Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial.Better prioritization to increase research value and decrease waste.Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis 1,25-Dihydroxyvitamin D3-Conditioned CD11c+ Dendritic Cells are Effective Initiators of CNS Autoimmune Disease.Network meta-analysis for comparing treatment effects of multiple interventions: an introduction.The contribution of imaging in the diagnosis and treatment of axial spondyloarthritis.Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis.Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics.Clinical trials: A transparent future for clinical trial reporting.Combination Therapy With and Without Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta-Analysis of Randomized Trials.Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices.Overlapping network meta-analyses on the same topic: survey of published studies.

P2860

Q33778719-4178BED0-15D6-4C6D-9450-1A8EDB6EA080 Q35174817-C7155C19-B144-47EB-AB82-78A86DD0C7CE Q35791171-08FAD576-C7AD-4D09-9BFC-03BB8972D8FE Q36086443-6ADE3975-58FC-4E2F-A08F-A722BCDF5AEF Q36292610-9FBD7C9B-8C66-41CF-8A15-3BCCEAC0CD26 Q38201284-4F09F9DC-4CEA-4859-ABE3-65A4835861F8 Q38265675-0F498444-B39C-4872-93EF-73D3E4B7F317 Q38334787-F79F65FE-0B10-4E7B-BB34-FEB9A11F632E Q38645738-66976429-47D5-4262-9881-4CDA3F59A408 Q39011096-705226A9-EBD5-4562-813C-7E05CD6DCE06 Q40924024-F3DFA239-79DC-40D0-8E89-61E5CB4F589B Q42742549-5A60D2DA-6E80-4420-8F34-6A7A7D5D32F2 Q50080887-102684D5-F651-42D1-ABC1-7183409978EA

P2860

Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales.

http://www.wikidata.org/entity/Q38133728

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales.

@en

type

label

Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales.

@en

prefLabel

Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales.

@en

P1433

Q38133728-20B56406-2ED0-46EB-9597-5490829AC119

P1476

Q38133728-9928ECE0-C589-499C-80BB-EC5B8022CBBF

P2093

Q38133728-A941368E-69A0-4FBD-9ED6-482B63766692

Q38133728-AFD9AC8D-75BF-4594-94B1-77E3931AFA69

Q38133728-C5AE6632-7D35-4908-BF77-D811D70B7230

Q38133728-F333DEAF-67A6-4DE1-9AAC-9921A626B15F

P2860

Q38133728-0A590FCB-358F-4DAD-A7EA-39F26EF901E5

Q38133728-10B2DE23-02CE-4CD5-8880-81FC2BDAC4FA

Q38133728-10F4E0C9-05F6-4A2F-8818-E6D840EA421C

Q38133728-117D3957-63D8-4540-86AE-05ED254FFFC9

Q38133728-13BF5424-1B8C-4D00-A3FF-DA5E588FF417

Q38133728-27DFF2C3-0760-4E92-8AB9-942BE1F994FB

Q38133728-29187DCE-A7E7-484A-BBE2-149183B3E377

Q38133728-2C5687B8-C2A7-40FD-8CAB-8D3134EAFD0A

Q38133728-30EDC9B3-F371-40B1-B72A-2CFF2E23C9A5

Q38133728-3DB74225-69A3-4B55-9D23-D5D0DED76261

P2888

Q38133728-64E1FBAA-6E7A-44E2-B221-A391A71EC1A5

P304

Q38133728-F7F16F01-A7B9-408B-81A6-8FCD3A8398EF

P31

Q38133728-54B4EE62-DFBC-458C-8A4D-34F243E08B3C

P356

Q38133728-D01368E5-4189-4CC5-9195-D73426D40FCC

P407

Q38133728-7AD96CEC-3A67-4323-8E31-ED5BDA584EF2

P433

Q38133728-88AA09B6-BC09-4A67-8979-033D60FD0CDF

P478

Q38133728-2C94E35F-252A-4FDB-8335-084C7BE4FBB7

P50

Q38133728-AEA278A0-AC07-42B5-9CB0-EFD86FD06987

P577

Q38133728-1CA78192-428E-4331-8E78-E5FC677FF014

P6179

Q38133728-5A9506A2-7D12-4F05-9790-2EE727CE6632

P698

Q38133728-B71C6AAA-0FC1-4B14-A69A-DF8C9CC16EDD

P356

NRRHEUM.2013.134

P1433

Nature Reviews Rheumatology

P1476

Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales.

@en

P2093

Edward J Mills

http://www.w3.org/2001/XMLSchema#string

Eric Druyts

http://www.w3.org/2001/XMLSchema#string

Fotini B Karassa

http://www.w3.org/2001/XMLSchema#string

Kristian Thorlund

http://www.w3.org/2001/XMLSchema#string

P2860

Outcome reporting among drug trials registered in ClinicalTrials.gov

Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

Incomplete reporting of recruitment information in clinical trials of biologic agents for the treatment of rheumatoid arthritis: a review

Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research

Reference bias in reports of drug trials.

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

Systematic review of the empirical evidence of study publication bias and outcome reporting bias

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

P2888

nrrheum.2013.134

P304

665-673

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRRHEUM.2013.134

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

John P. A. Ioannidis

P577

2013-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1019380329

http://www.w3.org/2001/XMLSchema#string

P698

23999553

http://www.w3.org/2001/XMLSchema#string